Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;25(1):211-219.
doi: 10.1007/s11605-020-04832-y. Epub 2020 Nov 2.

Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy

Affiliations

Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy

Sarina C Lowe et al. J Gastrointest Surg. 2021 Jan.

Abstract

Background: Medical therapy for inflammatory bowel disease (IBD) has markedly advanced since the introduction of biologic therapeutics, although surgery remains an important therapeutic strategy for both Crohn's disease (CD) and ulcerative colitis (UC). This study evaluated how rates of bowel resection surgery and post-operative mortality for IBD have changed over the last decade in the era of biologic therapies.

Methods: The Nationwide Readmission Database (NRD) was queried for patients with IBD (based on ICD-9 and -10 diagnosis and procedure codes) who were hospitalized between 2010 and 2017. Longitudinal trends in bowel resection surgery, urgent surgery, and post-operative mortality were analyzed.

Results: During the 8-year period, a total of 1795,266 IBD-related hospitalizations (1,072,110 with CD and 723,156 with UC) were evaluated. There was an increase in the annual number of IBD patients hospitalized, but a statistically significant decrease in the proportion of IBD patients undergoing surgery, from 10 to 8.8% (p < 0.001) for CD and 7.7 to 7.5% (p < 0.001) for UC. From 2014 through 2017, the proportion of urgent surgeries remained stable around 25% (p = 0.16) for CD and decreased from 21 to 14% (p < 0.001) for UC. For CD, the rate of post-operative 30-day mortality varied between 1.2 and 1.6% and for UC decreased from 5.8 to 2.3% (p < 0.001).

Conclusions: Analysis of a nationwide dataset from 2010 to 2017 determined that despite an increase in total admissions for IBD, a smaller proportion of hospitalized patients underwent surgery. A greater proportion of surgeries for UC were performed on an elective basis, and overall the rates of post-operative mortality for CD and UC decreased. The growth of biologic medical therapy during the study period highlights a probable contributing factor for the observed changes.

Keywords: Biologic era; Crohn’s disease; Inflammatory bowel disease; Post-operative mortality; Surgery; Ulcerative colitis; Urgent.

PubMed Disclaimer

References

    1. San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I. Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors. JAMA Intern Med. 2019;179(5):713–6. https://doi.org/10.1001/jamainternmed.2018.7656 . - DOI - PubMed - PMC
    1. Armuzzi A, DiBonaventura MD, Tarallo M, Lucas J, Bluff D, Hoskin B et al. Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe. PLoS One. 2020;15(1):e0227914. https://doi.org/10.1371/journal.pone.0227914 . - DOI - PubMed - PMC
    1. Targownik LE, Tennakoon A, Leung S, Lix LM, Singh H, Bernstein CN. Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis. Clin Gastroenterol Hepatol. 2017;15(7):1061–70 e1. https://doi.org/10.1016/j.cgh.2017.01.035 . - DOI - PubMed
    1. Carter MJ, Lobo AJ, Travis SP, Ibd Section BSoG. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53 Suppl 5:V1–16. https://doi.org/10.1136/gut.2004.043372 .
    1. Andrews HA, Lewis P, Allan RN. Prognosis after surgery for colonic Crohn’s disease. Br J Surg. 1989;76(11):1184–90. https://doi.org/10.1002/bjs.1800761123 . - DOI - PubMed

LinkOut - more resources